register of innovative drugs products for human use - active data protection period · 2021. 1....
TRANSCRIPT
Products for Human Use - Active Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal
Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
abemaciclib 215268 Verzenio Eli Lilly Canada Inc. N/A 2019-04-08 2025-04-08 N/A 2027-04-08
acalabrutinib 214504 Calquence AstraZeneca Canada Inc. N/A 2019-08-23 2025-08-23 N/A 2027-08-23
aclidinium bromide 157598 Tudorza Genuair AstraZeneca Canada Inc. Duaklir Genuair 2013-07-29 2019-07-29 N/A 2021-07-29
afatinib dimaleate 158730 Giotrif Boehringer Ingelheim (Canada) Ltd. N/A 2013-11-01 2019-11-01 N/A 2021-11-01
aflibercept 149321 Eylea Bayer Inc. N/A 2013-11-08 2019-11-08 N/A 2021-11-08
albiglutide 165145 Eperzan GlaxoSmithKline Inc. N/A 2015-07-15 2021-07-15 N/A 2023-07-15
alectinib hydrochloride 189442 Alecensaro Hoffmann-La Roche Limited N/A 2016-09-29 2022-09-29 N/A 2024-09-29
alirocumab 183116 Praluent Sanofi-aventis Canada Inc. N/A 2016-04-11 2022-04-11 N/A 2024-04-11
alogliptin benzoate 158335 Nesina Takeda Canada Inc. KazanoOseni
2013-11-27 2019-11-27 N/A 2021-11-27
alpelisib 226941 Piqray Novartis Pharmaceuticals Canada Inc. N/A 2020-03-11 2026-03-11 N/A 2028-03-11
amifampridine (supplied as amifampridine phosphate)
232685 Firdapse Kye Pharmaceuticals Inc. N/A 2020-07-31 2026-07-31 N/A 2028-07-31
anthrax antigen filtrate 212387 Biothrax Emergent Biodefense Operations Lansing LLC
N/A 2018-12-13 2024-12-13 N/A 2026-12-13
anthrax immune globulin (human)
200446 Anthrasil Emergent BioSolutions Canada Inc. N/A 2017-11-06 2023-11-06 Yes 2026-05-06
antihemophilic factor (recombinant BDD), Fc fusion protein
163447 Eloctate Sanofi-Aventis Canada Inc. N/A 2014-08-22 2020-08-22 Yes 2023-02-22
antihemophilic factor (recombinant), pegylated
189709 Adynovate Takeda Canada Inc. N/A 2016-11-17 2022-11-17 Yes 2025-05-17
Register Of Innovative Drugs
Page 1 of 34 2021-04-29
Products for Human Use - Active Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal
Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
antihemophilic factor (recombinant, B-domain deleted) (also known as simoctocog alfa)
169551 Nuwiq Octapharma Pharmazeutika Produktionsges.m.b.H
N/A 2014-10-23 2020-10-23 Yes 2023-04-23
antihemophilic factor (recombinant, B-domain deleted, pegylated) (also known as damoctocog alfa pegol)
210935 Jivi Bayer Inc. N/A 2018-10-18 2024-10-18 Yes 2027-04-18
antihemophilic factor VIII (recombinant), singlechain (also known as lonoctocog alfa)
190891 Afstyla CSL Behring Canada Inc. N/A 2016-12-12 2022-12-12 Yes 2025-06-12
antihemophilic factor VIII (recombinant, B-domain truncated), PEGylated (turoctocog alfa pegol)
218531 Esperoct Novo Nordisk Canada Inc. N/A 2019-07-04 2025-07-04 Yes 2028-01-04
apalutamide 211942 Erleada Janssen Inc. N/A 2018-07-03 2024-07-03 N/A 2026-07-03
apremilast 169862 Otezla Amgen Canada Inc. N/A 2014-11-12 2020-11-12 N/A 2022-11-12
asfotase alfa 179340 Strensiq Alexion Pharma International Sàrl N/A 2015-08-14 2021-08-14 Yes 2024-02-14
asunaprevir 172617 Sunvepra Bristol-Myers Squibb Canada N/A 2016-03-09 2022-03-09 N/A 2024-03-09
atezolizumab 196843 Tecentriq Hoffmann-La Roche Limited N/A 2017-04-12 2023-04-12 N/A 2025-04-12
avelumab 204052 Bavencio EMD Serono, a Division of EMD Inc., Canada
N/A 2017-12-18 2023-12-18 N/A 2025-12-18
axicabtagene ciloleucel 218389 Yescarta Gilead Sciences Canada Inc N/A 2019-02-13 2025-02-13 N/A 2027-02-13
azelastine hydrochloride 169604 Dymista Meda Pharmaceuticals Ltd. N/A 2014-10-23 2020-10-23 Yes 2023-04-23
baloxavir marboxil 227361 Xofluza Hoffmann-La Roche Limited N/A 2020-02-19 2026-02-19 Yes 2028-08-19
Page 2 of 34 2021-04-29
Products for Human Use - Active Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal
Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
baricitinib 193687 Olumiant Eli Lilly Canada Inc. N/A 2018-08-17 2024-08-17 N/A 2026-08-17
bazedoxifene acetate 160681 Duavive Pfizer Canada Inc. N/A 2014-10-23 2020-10-23 N/A 2022-10-23
benralizumab 204008 Fasenra AstraZeneca Canada Inc. N/A 2018-02-22 2024-02-22 Yes 2026-08-22
bepotastine besilate 179294 Bepreve Bausch and Lomb Incorporated N/A 2016-07-27 2022-07-27 Yes 2025-01-27
bictegravir 203718 Biktarvy Gilead Sciences Canada, Inc. N/A 2018-07-10 2024-07-10 Yes 2027-01-10
bilastine 184231 Blexten Aralez Pharmaceutials Canada Inc. N/A 2016-04-21 2022-04-21 Yes 2024-10-21
binimetinib 237410 Mektovi Pfizer Canada ULC N/A 2021-03-02 2027-03-02 N/A 2029-03-02
blinatumomab 181723 Blincyto Amgen Canada Incorporated N/A 2015-12-22 2021-12-22 Yes 2024-06-22
bosutinib 152211 Bosulif Pfizer Canada Inc. N/A 2014-03-07 2020-03-07 N/A 2022-03-07
botulism antitoxin heptavalent C/ D/F/ G – (equine)
190645 Bat Emergent BioSolutions Inc. N/A 2016-12-08 2022-12-08 Yes 2025-06-08
brexpiprazole 192684 Rexulti Otsuka Pharmaceutical Co. Ltd. N/A 2017-02-16 2023-02-16 Yes 2025-08-16
brigatinib 210369 Alunbrig Takeda Canada Incorporated N/A 2018-07-26 2024-07-26 N/A 2026-07-26
brivaracetam 183355 Brivlera UCB Canada Incorporated N/A 2016-03-09 2022-03-09 Yes 2024-09-09
brodalumab 195317 Siliq Bausch Health, Canada Inc. N/A 2018-03-06 2024-03-06 N/A 2026-03-06
brolucizumab 226224 Beovu Novartis Pharmaceuticals Canada Inc. N/A 2020-03-12 2026-03-12 N/A 2028-03-12
bromfenac sodium sesquihydrate
171657 Prolensa Bausch & Lomb Incorporated N/A 2015-03-26 2021-03-26 N/A 2023-03-26
burosumab 216239 Crysvita Kyowa Kirin Limited N/A 2018-12-05 2024-12-05 Yes 2027-06-05
Page 3 of 34 2021-04-29
Products for Human Use - Active Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal
Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
cabotegravir 227315 Cabenuva ViiV Healthcare ULC N/A 2020-03-18 2026-03-18 N/A 2028-03-18
cabotegravir sodium 227315 Vocabria ViiV Healthcare ULC N/A 2020-03-18 2026-03-18 N/A 2028-03-18
cabozantinib (supplied as cabozantinib (S)-malate)
206230 Cabometyx Ipsen Biopharmaceuticals Canada Inc. N/A 2018-09-14 2024-09-14 N/A 2026-09-14
calcifediol 205392 Rayaldee Vifor Fresenius Medical Care Renal Pharma Ltd
N/A 2018-07-10 2024-07-10 N/A 2026-07-10
canagliflozin 157505 Invokana Janssen Inc. InvokametInvokamet XR
2014-05-23 2020-05-23 N/A 2022-05-23
caplacizumab 230001 Cablivi Sanofi-Aventis Canada Inc. N/A 2020-02-28 2026-02-28 N/A 2028-02-28
carfilzomib 184479 Kyprolis Amgen Canada Inc. N/A 2016-01-15 2022-01-15 N/A 2024-01-15
carglumic acid 171358 Carbaglu Recordati Rare Diseases N/A 2015-04-10 2021-04-10 Yes 2023-10-10
cedazuridine 234610 Inqovi Otsuka Pharmaceutical Co., Ltd. NA 2020-07-07 2026-07-07 N/A 2028-07-07
ceftolozane 178006 Zerbaxa Merck Canada Inc. N/A 2015-09-30 2021-09-30 N/A 2023-09-30
cemiplimab 218718 Libtayo Sanofi-Aventis Canada Inc. N/A 2019-04-10 2025-04-10 N/A 2027-04-10
cenegermin 218145 Oxervate Dompé farmaceutici S.p.A. N/A 2019-02-08 2025-02-08 N/A 2027-02-08
ceritinib 175702 Zykadia Novartis Pharmaceuticals Canada Inc. N/A 2015-03-27 2021-03-27 N/A 2023-03-27
cerliponase alfa 216539 Brineura Biomarin International Limited N/A 2018-12-19 2024-12-19 Yes 2027-06-19
coagulation factor IX (recombinant), albumin fusion protein (rIX-FP)
180793 Idelvion CSL Behring Canada Inc. N/A 2016-01-26 2022-01-26 Yes 2024-07-26
Page 4 of 34 2021-04-29
Products for Human Use - Active Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal
Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
coagulation factor IX (recombinant), pegylated (nonacog beta pegol)
201114 Rebinyn Novo Nordisk Canada Inc. N/A 2017-11-29 2023-11-29 Yes 2026-05-29
coagulation factor IX, Fc fusion protein
163614 Alprolix Sanofi-Aventis Canada Inc. N/A 2014-03-20 2020-03-20 Yes 2022-09-20
cobimetinib 182788 Cotellic Hoffmann-La Roche Limited N/A 2016-02-22 2022-02-22 N/A 2024-02-22
crisaborole 206906 Eucrisa Pfizer Canada Inc. N/A 2018-06-07 2024-06-07 Yes 2026-12-07
cysteamine bitartrate 191347 Procysbi Horizon Pharma Ireland Ltd. N/A 2017-06-13 2023-06-13 Yes 2025-12-13
dabrafenib mesylate 157590 Tafinlar Novartis Pharmaceuticals Canada Inc. N/A 2013-07-16 2019-07-16 N/A 2021-07-16
daclatasvir 172616 Daklinza Bristol-Myers Squibb Canada N/A 2015-08-13 2021-08-13 N/A 2023-08-13
daclizumab beta 190458 Zinbryta Biogen Canada Inc. N/A 2016-12-08 2022-12-08 N/A 2024-12-08
dacomitinib 214572 Vizimpro Pfizer Canada Inc. N/A 2019-02-26 2025-02-26 N/A 2027-02-26
dalbavancin (supplied as dalbavancin hydrochloride)
212390 Xydalba Cipher Pharmaceuticals Inc. N/A 2018-09-04 2024-09-04 N/A 2026-09-04
dapagliflozin propanediol 160877 Forxiga AstraZeneca Canada Inc. XigduoQtern
2014-12-12 2020-12-12 N/A 2022-12-12
daratumumab 187648 Darzalex Janssen Inc. Darzalex SC 2016-06-29 2022-06-29 N/A 2024-06-29
darolutamide 226146 Nubeqa Bayer Inc. N/A 2020-02-20 2026-02-20 N/A 2028-02-20
deferiprone 162924 Ferriprox Chiesi Canada Corp. N/A 2015-02-13 2021-02-13 Yes 2023-08-13
defibrotide sodium 200808 Defitelio Jazz Pharmaceuticals Ireland Limited N/A 2017-07-10 2023-07-10 Yes 2026-01-10
difluprednate 154517 Durezol Novartis Pharmaceuticals Canada Inc. N/A 2013-11-04 2019-11-04 Yes 2022-05-04
Page 5 of 34 2021-04-29
Products for Human Use - Active Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal
Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
dimethyl fumarate 154776 Tecfidera Biogen Idec Canada Inc. N/A 2013-04-03 2019-04-03 Yes 2021-10-03
dinutuximab 212066 Unituxin United Therapeutics Corporation N/A 2018-11-28 2024-11-28 Yes 2027-05-28
dolutegravir sodium 161084 Tivicay ViiV Healthcare ULC TriumeqJulucaDovato
2013-10-31 2019-10-31 Yes 2022-05-01
doravirine 211293 Pifeltro Merck Canada Inc. Delstrigo 2018-10-12 2024-10-12 N/A 2026-10-12
dulaglutide 168671 Trulicity Eli Lilly Canada Inc. N/A 2015-11-10 2021-11-10 N/A 2023-11-10
dupilumab 201285 Dupixent Sanofi-Aventis Canada Inc. N/A 2017-11-30 2023-11-30 Yes 2026-05-30
durvalumab 202953 Imfinzi AstraZeneca Canada Inc. N/A 2017-11-03 2023-11-03 N/A 2025-11-03
edaravone 214391 Radicava Mitsubishi Tanabe Pharma Corporation N/A 2018-10-03 2024-10-03 N/A 2026-10-03
edoxaban 187363 Lixiana Servier Canada Inc. N/A 2016-11-04 2022-11-04 N/A 2024-11-04
efinaconazole 159416 Jublia Valeant Canada LP / Valeant Canada S.E.C. N/A 2013-10-02 2019-10-02 N/A 2021-10-02
elagolix 209513 Orilissa AbbVie Corporation N/A 2018-10-05 2024-10-05 N/A 2026-10-05
eliglustat tartrate 183050 Cerdelga Genzyme Canada, A division of Sanofi-aventis Canada Inc.
N/A 2017-04-21 2023-04-21 N/A 2025-04-21
elosulfase alfa 170340 Vimizim Biomarin International Limited N/A 2014-07-02 2020-07-02 Yes 2023-01-02
elotuzumab 188144 Empliciti Bristol-Myers Squibb Canada N/A 2016-06-21 2022-06-21 N/A 2024-06-21
eluxadoline 190162 Viberzi Allergan Inc. N/A 2017-01-26 2023-01-26 N/A 2025-01-26
emicizumab 212635 Hemlibra Hoffmann-La Roche Limited N/A 2018-08-02 2024-08-02 Yes 2027-02-02
Page 6 of 34 2021-04-29
Products for Human Use - Active Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal
Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
empagliflozin 162552 Jardiance Boehringer Ingelheim (Canada) Ltd. SynjardyGlyxambi
2015-07-23 2021-07-23 N/A 2023-07-23
enasidenib mesylate 217033 Idhifa Celgene Inc. N/A 2019-02-06 2025-02-06 N/A 2027-02-06
encorafenib 237413 Braftovi Pfizer Canada ULC N/A 2021-03-02 2027-03-02 N/A 2029-03-02
entrectinib 227517 Rozlytrek Hoffmann-La Roche Limited N/A 2020-02-10 2026-02-10 Yes 2028-08-10
enzalutamide 159678 Xtandi Astellas Pharma Canada Inc. N/A 2013-05-29 2019-05-29 N/A 2021-05-29
eptinezumab 233288 Vyepti Lundbeck Canada Inc. N/A 2021-01-11 2027-01-11 N/A 2029-01-11
erdafitinib 224529 Balversa Janssen Inc. N/A 2019-10-25 2025-10-25 N/A 2027-10-25
erenumab 208607 Aimovig Novartis Pharmaceuticals Canada Inc. N/A 2018-08-01 2024-08-01 N/A 2026-08-01
ertugliflozin 204724 Steglatro Merck Canada Inc. SteglujanSegluromet
2018-05-09 2024-05-09 N/A 2026-05-09
eslicarbazepine acetate 165665 Aptiom Sunovion Pharmaceuticals Canada Inc. N/A 2014-07-08 2020-07-08 Yes 2023-01-08
estetrol monohydrate 236197 Nextstellis Searchlight Pharma Inc. N/A 2021-03-05 2027-03-05 N/A 2029-03-05
evolocumab 178234 Repatha Amgen Canada Inc. N/A 2015-09-10 2021-09-10 Yes 2024-03-10
fedratinib (supplied as fedratinib hydrochloride)
229866 Inrebic Celgene Inc. N/A 2020-07-27 2026-07-27 N/A 2028-07-27
finafloxacin 172450 Xtoro MerLion Pharmaceuticals GmbH N/A 2016-03-11 2022-03-11 Yes 2024-09-11
flibanserin 189352 Addyi Searchlight Pharma Inc. N/A 2018-02-27 2024-02-27 N/A 2026-02-27
florbetaben (18F) 193105 Neuraceq Isologic Innovative Radiopharmaceuticals Ltd.
N/A 2017-02-22 2023-02-22 N/A 2025-02-22
follitropin delta 188743 Rekovelle Ferring Inc. N/A 2018-03-22 2024-03-22 N/A 2026-03-22
Page 7 of 34 2021-04-29
Products for Human Use - Active Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal
Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
fostamatinib (supplied as fostamatinib disodium)
232078 Tavalisse Rigel Pharmaceuticals Inc. N/A 2020-11-19 2026-11-19 N/A 2028-11-19
fremanezumab 226828 Ajovy Teva Canada Limited N/A 2020-04-09 2026-04-09 N/A 2028-04-09
gadoterate meglumine 186333 Dotarem Guerbet N/A 2016-11-26 2022-11-26 Yes 2025-05-26
galcanezumab 219521 Emgality Eli Lilly Canada Inc. N/A 2019-07-30 2025-07-30 N/A 2027-07-30
galsulfase 159020 Naglazyme BioMarin Pharmaceutical Inc. N/A 2013-09-16 2019-09-16 Yes 2022-03-16
gemtuzumab ozogamicin 223091 Mylotarg Pfizer Canada ULC N/A 2019-11-28 2025-11-28 Yes 2028-05-28
gilteritinib fumarate 227918 Xospata Astellas Pharma Canada Inc. N/A 2019-12-23 2025-12-23 N/A 2027-12-23
givosiran (supplied as givosiran sodium)
237194 Givlaari Alnylam Netherlands B.V. N/A 2020-10-09 2026-10-09 N/A 2028-10-09
glasdegib 225793 Daurismo Pfizer Canada ULC N/A 2020-04-28 2026-04-28 N/A 2028-04-28
glecaprevir, pibrentasvir 202233 Maviret AbbVie Corporation N/A 2017-08-16 2023-08-16 Yes 2026-02-16
glycerol phenylbutyrate 174219 Ravicti Horizon Pharma Ireland Ltd. N/A 2016-03-18 2022-03-18 Yes 2024-09-18
grazoprevir, elbasvir 185866 Zepatier Merck Canada Inc. N/A 2016-01-19 2022-01-19 N/A 2024-01-19
guanfacine hydrochloride 150741 Intuniv XR Takeda Canada Inc. N/A 2013-07-05 2019-07-05 Yes 2022-01-05
guselkumab 200590 Tremfya Janssen Inc. N/A 2017-11-10 2023-11-10 N/A 2025-11-10
haemagglutinin strain A (H5N1) 115398 Arepanrix H5N1 ID Biomedical Corporation of Quebec N/A 2013-02-13 2019-02-13 Yes 2021-08-13
hemin 212276 Panhematin Recordati Rare Diseases Canada Inc. N/A 2018-07-13 2024-07-13 N/A 2026-07-13
ibrutinib 174029 Imbruvica Janssen Inc. N/A 2014-11-17 2020-11-17 Yes 2023-05-17
Page 8 of 34 2021-04-29
Products for Human Use - Active Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal
Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
icatibant acetate 162918 Firazyr Takeda Canada Inc. N/A 2014-06-04 2020-06-04 Yes 2022-12-04
icosapent ethyl 227235 Vascepa HLS Therapeutics Inc. N/A 2019-12-30 2025-12-30 N/A 2027-12-30
idarucizumab 182503 Praxbind Boehringer Ingelheim (Canada) Ltd N/A 2016-04-29 2022-04-29 N/A 2024-04-29
idelalisib 172652 Zydelig Gilead Sciences Canada Inc. N/A 2015-03-27 2021-03-27 N/A 2023-03-27
inotersen sodium 214274 Tegsedi Akcea Therapeutics Inc. N/A 2018-10-03 2024-10-03 N/A 2026-10-03
inotuzumab ozogamicin 204077 Besponsa Pfizer Canada Inc. N/A 2018-03-15 2024-03-15 N/A 2026-03-15
insulin degludec 198124 Tresiba Novo Nordisk Canada Inc. Xultophy 2017-08-25 2023-08-25 Yes 2026-02-25
ioflupane (123I) 201481 Datscan GE Healthcare Canada Inc. N/A 2017-12-07 2023-12-07 N/A 2025-12-07
iron isomaltoside 1000 193890 Monoferric Pharmacosmos A/S N/A 2018-06-22 2024-06-22 N/A 2026-06-22
isatuximab 229245 Sarclisa Sanofi-Aventis Canada Inc. N/A 2020-04-29 2026-04-29 N/A 2028-04-29
isavuconazole (supplied as isavuconazonium sulfate)
208919 Cresemba Avir Pharma Inc. N/A 2018-12-19 2024-12-19 N/A 2026-12-19
ivabradine hydrochloride 166949 Lancora Servier Canada Inc. N/A 2016-12-23 2022-12-23 Yes 2025-06-23
ivacaftor 155318 Kalydeco Vertex Pharmaceuticals (Canada) Inc. OrkambiSymdeko
2012-11-26 2018-11-26 Yes 2021-05-26
ivermectin 172733 Rosiver Galderma Canada Inc. N/A 2015-04-22 2021-04-22 N/A 2023-04-22
ixazomib (supplied as ixazomib citrate)
190498 Ninlaro Takeda Canada Inc. N/A 2016-08-04 2022-08-04 N/A 2024-08-04
ixekizumab 184993 Taltz Eli Lilly Canada Inc. N/A 2016-05-25 2022-05-25 Yes 2024-11-25
Page 9 of 34 2021-04-29
Products for Human Use - Active Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal
Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
lanadelumab 213920 Takhzyro Takeda Canada Inc. N/A 2018-09-19 2024-09-19 Yes 2027-03-19
larotrectinib (supplied as larotrectinib sulfate)
219998 Vitrakvi Bayer Inc. N/A 2019-07-10 2025-07-10 Yes 2028-01-10
latanoprostene bunod 211732 Vyzulta Bausch & Lomb Incorporated N/A 2018-12-27 2024-12-27 N/A 2026-12-27
ledipasvir 173180 Harvoni Gilead Sciences Canada Inc. N/A 2014-10-15 2020-10-15 Yes 2023-04-15
lefamulin acetate 233292 Xenleta Sunovion Pharmaceuticals Canada Inc. N/A 2020-07-10 2026-07-10 N/A 2028-07-10
lemborexant 231286 Dayvigo Eisai Limited N/A 2020-11-04 2026-11-04 N/A 2028-11-04
lenvatinib mesylate 180877 Lenvima Eisai Limited N/A 2015-12-22 2021-12-22 N/A 2023-12-22
letermovir 204165 Prevymis Merck Canada Inc. N/A 2017-11-01 2023-11-01 N/A 2025-11-01
levomilnacipran hydrochloride 167319 Fetzima Allergan Inc. N/A 2015-05-08 2021-05-08 N/A 2023-05-08
lifitegrast 199810 Xiidra Novartis Pharmaceuticals Canada Inc. N/A 2017-12-22 2023-12-22 N/A 2025-12-22
linaclotide 161056 Constella Forest Laboratories Canada Inc. N/A 2013-12-02 2019-12-02 N/A 2021-12-02
lixisenatide 193862 Adlyxine Sanofi-aventis Canada Inc. Soliqua 2017-05-25 2023-05-25 N/A 2025-05-25
lomitapide mesylate 160385 Juxtapid Aegerion Pharmaceuticals Canada Ltd. N/A 2014-02-04 2020-02-04 N/A 2022-02-04
lorlatinib 215733 Lorbrena Pfizer Canada ULC N/A 2019-02-22 2025-02-22 N/A 2027-02-22
lubiprostone 179333 Amitiza Sucampo Pharma Americas LLC N/A 2015-10-14 2021-10-14 N/A 2023-10-14
lumacaftor 181715 Orkambi Vertex Pharmaceuticals (Canada) Incorporated
N/A 2016-01-26 2022-01-26 Yes 2024-07-26
Page 10 of 34 2021-04-29
Products for Human Use - Active Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal
Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
luspatercept 236441 Reblozyl Celgene Inc. N/A 2020-09-25 2026-09-25 N/A 2028-09-25
lutetium 177Lu oxodotreotide 217184 Lutathera Advanced Accelerator Applications USA, Inc.
N/A 2019-01-09 2025-01-09 N/A 2027-01-09
macitentan 161372 Opsumit Janssen Inc. N/A 2013-11-06 2019-11-06 Yes 2022-05-06
mecasermin 235023 Increlex Ipsen Biopharmaceuticals Canada Inc. N/A 2020-12-17 2026-12-17 Yes 2029-06-17
mepolizumab 179850 Nucala GlaxoSmithKline Inc. N/A 2015-12-03 2021-12-03 Yes 2024-06-03
midostaurin 201101 Rydapt Novartis Pharmaceuticals Canada Inc. N/A 2017-07-21 2023-07-21 Yes 2026-01-21
mifepristone 160063 Mifegymiso Linepharma International Limited N/A 2015-07-29 2021-07-29 Yes 2024-01-29
migalastat hydrochloride 196956 Galafold Amicus Therapeutics UK LTD N/A 2017-09-05 2023-09-05 N/A 2025-09-05
modified vaccinia virus (ankara-bavarian nordic)
144762 Imvamune Bavarian Nordic A/S N/A 2013-11-21 2019-11-21 N/A 2021-11-21
naloxegol oxalate 167790 Movantik Knight Therapeutics Inc. N/A 2015-06-02 2021-06-02 N/A 2023-06-02
necitumumab 193689 Portrazza Eli Lilly Canada Inc. N/A 2017-03-16 2023-03-16 N/A 2025-03-16
neisseria meningitidis serogroup A polysaccharide, neisseria meningitidis serogroup C polysaccharide, neisseria meningitidis serogroup W-135 polysaccharide, neisseria meningitidis serogroup Y polysaccharide, conjugated to tetanus toxoid carrier protein
154290 Nimenrix Pfizer Canada Inc. N/A 2013-03-05 2019-03-05 Yes 2021-09-05
Page 11 of 34 2021-04-29
Products for Human Use - Active Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal
Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
Neisseria meningitidis serogroup B recombinant lipoprotein 2086 (rLP2086) subfamily A and Neisseria meningitidis serogroup B recombinant lipoprotein 2086 (rLP2086) subfamily B
195550 Trumenba Pfizer Canada Inc. N/A 2017-10-05 2023-10-05 Yes 2026-04-05
neratinib maleate 218224 Nerlynx Knight Therapeutics Inc. N/A 2019-07-16 2025-07-16 N/A 2027-07-16
netupitant 196495 Akynzeo Elvium Life Sciences N/A 2017-09-28 2023-09-28 N/A 2025-09-28
nintedanib (supplied as nintedanib esilate)
176043 Ofev Boehringer Ingelheim (Canada) Ltd N/A 2015-06-25 2021-06-25 N/A 2023-06-25
niraparib 216792 Zejula GlaxoSmithKline Inc. N/A 2019-06-27 2025-06-27 N/A 2027-06-27
nivolumab 180828 Opdivo Bristol-Myers-Squibb Canada N/A 2015-09-25 2021-09-25 N/A 2023-09-25
nusinersen 200070 Spinraza Biogen Canada Inc. N/A 2017-06-29 2023-06-29 Yes 2025-12-29
obeticholic acid 198418 Ocaliva Intercept Pharmaceuticals Inc. N/A 2017-05-24 2023-05-24 N/A 2025-05-24
obiltoxaximab 230825 Anthim Elusys Therapeutics, Inc. N/A 2020-07-30 2026-07-30 N/A 2028-07-30
obinutuzumab 168227 Gazyva Hoffmann-La Roche Limited N/A 2014-11-25 2020-11-25 N/A 2022-11-25
ocrelizumab 198094 Ocrevus Hoffmann-La Roche Limited N/A 2017-08-14 2023-08-14 N/A 2025-08-14
ocriplasmin 161356 Jetrea ThromboGenics N.V. N/A 2013-08-13 2019-08-13 N/A 2021-08-13
olaparib 182823 Lynparza AstraZeneca Canada Inc. N/A 2016-04-29 2022-04-29 N/A 2024-04-29
olaratumab 203478 Lartruvo Eli Lilly Canada Inc. N/A 2017-11-23 2023-11-23 N/A 2025-11-23
olodaterol hydrochloride 155649 Striverdi Respimat Boehringer Ingelheim (Canada) Ltd. Inspiolto Respimat 2013-06-11 2019-06-11 N/A 2021-06-11
ombitasvir, paritaprevir, dasabuvir sodium
174739 Holkira Pak Abbvie Corporation Technivie 2014-12-22 2020-12-22 N/A 2022-12-22
Page 12 of 34 2021-04-29
Products for Human Use - Active Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal
Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
onasemnogene abeparvovec 239719 Zolegensma Novartis Pharmaceuticals Canada Inc. N/A 2020-12-15 2026-12-15 Yes 2029-06-15
osimertinib mesylate 188171 Tagrisso AstraZeneca Canada Inc. N/A 2016-07-05 2022-07-05 N/A 2024-07-05
ozanimod (supplied as ozanimod hydrochloride)
232761 Zeposia Celgene Inc. N/A 2020-10-02 2026-10-02 N/A 2028-10-02
ozenoxacin 192925 Ozanex Ferrer Internacional, S.A. N/A 2017-05-01 2023-05-01 Yes 2025-11-01
palbociclib 182048 Ibrance Pfizer Canada Inc. N/A 2016-03-16 2022-03-16 N/A 2024-03-16
pasireotide diaspartate 145005 Signifor Novartis Pharmaceuticals Canada Inc. Signifor Lar 2013-09-23 2019-09-23 N/A 2021-09-23
patiromer sorbitex calcium 210368 Veltassa Vifor Fresenius Medical Care Renal Pharma Ltd.
N/A 2018-10-03 2024-10-03 N/A 2026-10-03
patisiran (as patisiran sodium) 221896 Onpattro Alnylam Netherlands B.V. N/A 2019-06-07 2025-06-07 N/A 2027-06-07
peginterferon beta-1a 166974 Plegridy Biogen Idec Canada Inc. N/A 2015-08-10 2021-08-10 N/A 2023-08-10
pembrolizumab 175884 Keytruda Merck Canada Inc. N/A 2015-05-19 2021-05-19 Yes 2023-11-19
peramivir 191280 Rapivab BioCryst Pharmaceuticals Inc. N/A 2017-01-05 2023-01-05 N/A 2025-01-05
perampanel 153747 Fycompa Eisai Limited N/A 2013-04-04 2019-04-04 Yes 2021-10-04
plecanatide 215288 Trulance Cipher Pharmaceuticals Inc. N/A 2019-10-10 2025-10-10 N/A 2027-10-10
polatuzumab vedotin 232303 Polivy Hoffmann-La Roche Limited N/A 2020-07-09 2026-07-09 N/A 2028-07-09
polidocanol 177359 Varithena Provensis Ltd. N/A 2015-08-04 2021-08-04 N/A 2023-08-04
pomalidomide 165891 Pomalyst Celgene Inc. N/A 2014-01-20 2020-01-20 Yes 2022-07-20
ponatinib hydrochloride 165121 Iclusig Ariad Pharmaceuticals Inc. N/A 2015-04-02 2021-04-02 N/A 2023-04-02
pralatrexate 207545 Folotyn Servier Canada Inc. N/A 2018-10-26 2024-10-26 N/A 2026-10-26
Page 13 of 34 2021-04-29
Products for Human Use - Active Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal
Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
prasterone 198822 Intrarosa Endoceutics Inc. N/A 2019-11-01 2025-11-01 N/A 2027-11-01
propiverine hydrochloride 188323 Mictoryl / Mictoryl Pediatric Duchesnay Inc. N/A 2017-01-05 2023-01-05 Yes 2025-07-05
radium - 223 dichloride 161312 Xofigo Bayer Inc. N/A 2013-12-12 2019-12-12 N/A 2021-12-12
ramucirumab 176810 Cyramza Eli Lilly Canada Inc. N/A 2015-07-16 2021-07-16 N/A 2023-07-16
ravulizumab 217955 Ultomiris Alexion Pharma GmbH N/A 2019-08-28 2025-08-28 N/A 2027-08-28
recombinant haemagglutinin protein-strain A (H1N1) recombinant haemagglutinin protein-strain A (H3N2) recombinant haemagglutinin protein-strain B (Victoria) recombinant haemagglutinin protein-strain B (Yamagata)
235672 Supemtek Sanofi Pasteur Limited N/A 2021-01-14 2027-01-14 N/A 2029-01-14
recombinant human papillomavirus types 31, 33, 45, 52 and 58
170006 Gardasil 9 Merck Canada Inc. N/A 2015-02-05 2021-02-05 Yes 2023-08-05
recombinant neisseria meningitidis group B NHBA fusion protein, recombinant neisseria meningitidis group B NadA protein, recombinant neisseria meningitidis group B FHBP fusion protein, outer membrane vesicle (neisseria meningitidis group B NZ98/254 strain)
147275 Bexsero GlaxoSmithKline Inc. N/A 2013-12-06 2019-12-06 Yes 2022-06-06
recombinant porcine factor VIII (antihemophilic factor (recombinant), porcine sequence)
177290 Obizur Takeda Canada Inc. N/A 2015-10-14 2021-10-14 N/A 2023-10-14
Page 14 of 34 2021-04-29
Products for Human Use - Active Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal
Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
regorafenib monohydrate 157970 Stivarga Bayer Inc. N/A 2013-03-11 2019-03-11 Yes 2021-09-11
remdesivir 240551 Veklury Gilead Sciences Canada, Inc. N/A 2020-07-27 2026-07-27 N/A 2028-07-27
reslizumab 185873 Cinqair Teva Canada Limited N/A 2016-07-20 2022-07-20 Yes 2025-01-20
ribociclib (supplied as ribociclib succinate)
203884 Kisqali Novartis Pharmaceuticals Canada Inc. N/A 2018-03-02 2024-03-02 N/A 2026-03-02
rifaximin 161256 Zaxine Salix Pharmaceuticals Inc. N/A 2013-08-13 2019-08-13 N/A 2021-08-13
riociguat 162761 Adempas Bayer Inc. N/A 2013-09-19 2019-09-19 N/A 2021-09-19
ripretinib 234688 Qinlock Deciphera Pharmaceuticals, LLC N/A 2020-06-19 2026-06-19 N/A 2028-06-19
risankizumab 215753 Skyrizi AbbVie Corporation N/A 2019-04-17 2025-04-17 N/A 2027-04-17
risdiplam 242373 Evrysdi Hoffman-La Roche Limited N/A 2021-04-14 2027-04-14 Yes 2029-10-14
romidepsin 152293 Istodax Celgene Inc. N/A 2013-10-16 2019-10-16 N/A 2021-10-16
romosozumab 197713 Evenity Amgen Canada Inc. N/A 2019-06-17 2025-06-17 N/A 2027-06-17
rupatadine (supplied as rupatadine fumarate)
186488 Rupall Medexus Pharmaceuticals Inc. N/A 2016-07-20 2022-07-20 Yes 2025-01-20
sacubitril 182734 Entresto Novartis Pharmaceuticals Canada Inc. N/A 2015-10-02 2021-10-02 N/A 2023-10-02
safinamide (as safinamide mesylate)
207115 Onstryv Valeo Pharma Inc. N/A 2019-01-10 2025-01-10 N/A 2027-01-10
sarilumab 191745 Kevzara Sanofi-aventis Canada Inc. N/A 2017-01-12 2023-01-12 N/A 2025-01-12
satralizumab 233642 Enspryng Hoffmann-La Roche Limited N/A 2020-06-01 2026-06-01 Yes 2028-12-01
sebelipase alfa 204085 Kanuma Alexion Pharma GmbH N/A 2017-12-15 2023-12-15 Yes 2026-06-15
Page 15 of 34 2021-04-29
Products for Human Use - Active Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal
Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
secukinumab 170732 Cosentyx Novartis Pharmaceuticals Canada Inc. N/A 2015-02-27 2021-02-27 Yes 2023-08-27
selexipag 182114 Uptravi Janssen Inc. N/A 2016-01-20 2022-01-20 N/A 2024-01-20
semaglutide 202059 Ozempic Novo Nordisk Canada Inc. Rybelsus 2018-01-04 2024-01-04 N/A 2026-01-04
siltuximab 174291 Sylvant EUSA Pharma (UK) Limited N/A 2014-12-03 2020-12-03 N/A 2022-12-03
simeprevir 164021 Galexos Janssen Inc. N/A 2013-11-18 2019-11-18 N/A 2021-11-18
siponimod 223225 Mayzent Novartis Pharmaceuticals Canada Inc. N/A 2020-02-20 2026-02-20 N/A 2028-02-20
sodium zirconium cyclosilicate 218799 Lokelma AstraZeneca Canada Inc. N/A 2019-07-25 2025-07-25 N/A 2027-07-25
sofosbuvir 165043 Sovaldi Gilead Sciences Canada Inc. Harvoni Epclusa Vosevi
2013-12-13 2019-12-13 N/A 2021-12-13
sonidegib phosphate 229407 Odomzo Sun Pharma Global FZE N/A 2020-06-12 2026-06-12 N/A 2028-06-12
stiripentol 142417 Diacomit Biocodex SA N/A 2012-12-21 2018-12-21 Yes 2021-06-21
sucroferric oxyhydroxide 201492 Velphoro Vifor Fresenius Medical Care Renal Pharma Ltd.
N/A 2018-01-05 2024-01-05 N/A 2026-01-05
sugammadex sodium 180385 Bridion Merck Canada Inc. N/A 2016-02-05 2022-02-05 N/A 2024-02-05
suvorexant 196367 Belsomra Merck Canada Inc. N/A 2018-11-29 2024-11-29 N/A 2026-11-29
tafamidis meglumine 228368 Vyndaqel Pfizer Canada ULC N/A 2020-01-20 2026-01-20 N/A 2028-01-20
tafluprost 165596 Saflutan Purdue Pharma N/A 2014-05-26 2020-05-26 N/A 2022-05-26
talazoparib (supplied as talazoparib tosylate)
220584 Talzenna Pfizer Canada ULC N/A 2019-09-06 2025-09-06 N/A 2027-09-06
Page 16 of 34 2021-04-29
Products for Human Use - Active Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal
Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
taliglucerase alfa 140854 Elelyso Pfizer Canada Inc. N/A 2014-05-29 2020-05-29 Yes 2022-11-29
tedizolid phosphate 173603 Sivextro Merck Canada Inc. N/A 2015-03-17 2021-03-17 N/A 2023-03-17
teduglutide 180223 Revestive Takeda Canada Inc. N/A 2015-09-04 2021-09-04 Yes 2024-03-04
telotristat ethyl (as telotristat etiprate)
208730 Xermelo Ipsen Biopharmaceuticals Canada Inc. N/A 2018-10-10 2024-10-10 N/A 2026-10-10
tenapanor hydrochloride 224850 Ibsrela Knight Therapeutics Inc. N/A 2020-04-15 2026-04-15 N/A 2028-04-15
tenofovir alafenamide hemifumarate
181399 Genvoya Gilead Sciences Canada Inc. DescovyOdefseyVemlidySymtuzaBiktarvy
2015-11-27 2021-11-27 Yes 2024-05-27
teriflunomide 160646 Aubagio Genzyme Canada a division of Sanofi-aventis Canada Inc.
N/A 2013-11-14 2019-11-14 Yes 2022-05-14
tesamorelin 131836 Egrifta Theratechnologies Inc. N/A 2014-04-29 2020-04-29 N/A 2022-04-29
tezacaftor 211292 Symdeko Vertex Pharmaceuticals (Canada) Incorporated
N/A 2018-06-27 2024-06-27 Yes 2026-12-27
tipiracil hydrochloride 205852 Lonsurf Taiho Pharma Canada Inc. N/A 2018-01-25 2024-01-25 N/A 2026-01-25
tisagenlecleucel 213547 /213698
Kymriah Novartis Pharmaceuticals Canada Inc. N/A 2018-09-05 2024-09-05 Yes 2027-03-05
tofacitinib 154642 Xeljanz Pfizer Canada Inc. N/A 2014-04-17 2020-04-17 Yes 2022-10-17
trametinib 157665 Mekinist Novartis Pharmaceuticals Canada Inc. N/A 2013-07-18 2019-07-18 N/A 2021-07-18
trastuzumab deruxtecan 242104 Enhertu AstraZeneca Canada Inc. N/A 2021-04-15 2027-04-15 N/A 2029-04-15
trastuzumab emtansine 162414 Kadcyla Hoffmann-La Roche Limited N/A 2013-09-11 2019-09-11 N/A 2021-09-11
Page 17 of 34 2021-04-29
Products for Human Use - Active Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal
Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
trifarotene 221945 Aklief Galderma Canada Inc. N/A 2019-11-25 2025-11-25 Yes 2028-05-25
triheptanoin 242196 Dojolvi Ultragenyx Pharmaceutical Inc. N/A 2021-02-15 2027-02-15 Yes 2029-08-15
tucatinib 235295 Tukysa Seattle Genetics Inc. N/A 2020-06-05 2026-06-05 N/A 2028-06-05
turoctocog alfa 170796 Zonovate Novo Nordisk Canada Inc. N/A 2014-12-08 2020-12-08 Yes 2023-06-08
ulipristal acetate 156861 Fibristal Allergan Inc. N/A 2013-06-24 2019-06-24 N/A 2021-06-24
umeclidinium bromide 161585 Anoro Ellipta GlaxoSmithKline Inc. Incruse Ellipta 2013-12-23 2019-12-23 N/A 2021-12-23
upadacitinib 223734 Rinvoq AbbVie Corporation N/A 2019-12-23 2025-12-23 N/A 2027-12-23
varicella-zoster virus glycoprotein E (gE)
200244 Shingrix GlaxoSmithKline Inc. N/A 2017-10-13 2023-10-13 N/A 2025-10-13
vedolizumab 169414 Entyvio Takeda Canada Inc. N/A 2015-01-29 2021-01-29 Yes 2023-07-29
velpatasvir 190521 Epclusa Gilead Sciences Canada Inc. Vosevi 2016-07-11 2022-07-11 Yes 2025-01-11
venetoclax 190761 Venclexta AbbVie Corporation N/A 2016-09-30 2022-09-30 N/A 2024-09-30
vernakalant hydrochloride 190817 Brinavess Cipher Pharmaceuticals Inc. N/A 2017-03-13 2023-03-13 N/A 2025-03-13
vilanterol trifenatate 157301 Breo Ellipta GlaxoSmithKline Inc. Anoro ElliptaTrelegy Ellipta
2013-07-03 2019-07-03 Yes 2022-01-03
vilazodone hydrochloride 176820 Viibryd Allergan Inc. N/A 2015-07-16 2021-07-16 Yes 2024-01-16
vismodegib 154608 Erivedge Hoffmann-La Roche Ltd. N/A 2013-07-12 2019-07-12 N/A 2021-07-12
von willebrand factor (recombinant) (vonicog alfa)
213188 Vonvendi Takeda Canada Inc. N/A 2019-01-10 2025-01-10 N/A 2027-01-10
Page 18 of 34 2021-04-29
Products for Human Use - Active Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal
Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
vorapaxar sulfate 179320 Zontivity Toprol Acquisition LLC N/A 2016-05-13 2022-05-13 N/A 2024-05-13
voretigene neparvovec 233097 Luxturna Novartis Pharmaceuticals Canada Inc. N/A 2020-10-13 2026-10-13 Yes 2029-04-13
vortioxetine hydrobromide 159019 Trintellix Lundbeck Canada Inc. N/A 2014-10-22 2020-10-22 Yes 2023-04-22
voxilaprevir 202324 Vosevi Gilead Sciences Canada Inc. N/A 2017-08-16 2023-08-16 N/A 2025-08-16
zanubrutinib 242748 Brukinsa BeiGene Switzerland GmbH N/A 2021-03-01 2027-03-01 N/A 2029-03-01
*The medicinal ingredient not previously approved in a drug by the Minister and that is not a variation of a previously approved medicinal ingredient (subsection C.08.004.1(1) of the Food and Drug Regulations ).
Page 19 of 34 2021-04-29
Products for Human Use - Expired Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
abatacept 098531 Orencia Bristol-Myers Squibb Canada N/A 2006-06-29 2012-06-29 Yes 2014-12-29
abiraterone acetate 138343 Zytiga Janssen Inc. N/A 2011-07-27 2017-07-27 N/A 2019-07-27
acamprosate calcium 103287 Campral Mylan Pharmaceuticals ULC N/A 2007-03-16 2013-03-16 N/A 2015-03-16
alglucosidase alfa 103381 Myozyme Genzyme Canada Inc. N/A 2006-08-14 2012-08-14 Yes 2015-02-14
aliskiren hemifumarate 105388 Rasilez Novartis Pharmaceuticals Canada Inc. Rasilez HCTRasilamlo
2007-11-14 2013-11-14 N/A 2015-11-14
ambrisentan 113287 Volibris GlaxoSmithKline Inc. N/A 2008-03-20 2014-03-20 N/A 2016-03-20
anidulafungin 110202 Eraxis Pfizer Canada Inc. N/A 2007-11-14 2013-11-14 Yes 2016-05-14
apixaban 141873 Eliquis Bristol-Myers Squibb Canada N/A 2011-12-16 2017-12-16 Yes 2020-06-16
aprepitant 108483 Emend Merck Frosst Canada Ltd. Emend Tri-PackEmend IV
2007-08-24 2013-08-24 N/A 2015-08-24
aripiprazole 120192 Abilify Bristol-Myers Squibb Canada Abilify Maintena 2009-07-09 2015-07-09 Yes 2018-01-09
asenapine maleate 127427 Saphris Merck Canada Inc. N/A 2011-10-07 2017-10-07 Yes 2020-04-07
axitinib 144404 Inlyta Pfizer Canada Inc. N/A 2012-07-12 2018-07-12 Yes 2021-01-12
azacitidine 127108 Vidaza Celgene N/A 2009-10-23 2015-10-23 N/A 2017-10-23
azilsartan medoxomil potassium
145305 Edarbi Valeant Canada LP Edarbyclor 2012-03-08 2018-03-08 N/A 2020-03-08
belimumab 137699 Benlysta GlaxoSmithKline Inc. N/A 2011-07-06 2017-07-06 N/A 2019-07-06
bendamustine hydrochloride 149814 Treanda Teva Canada Limited N/A 2012-08-24 2018-08-24 Yes 2021-02-24
besifloxacin 123400 Besivance Bausch & Lomb Inc. N/A 2009-10-23 2015-10-23 Yes 2018-04-23
boceprevir 141556 Victrelis Merck Canada Inc. Victrelis Triple 2011-07-29 2017-07-29 N/A 2019-07-29
Register Of Innovative Drugs
Page 20 of 34 2021-04-29
Products for Human Use - Expired Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
brentuximab vedotin 154851 Adcetris Seattle Genetics Inc. N/A 2013-02-01 2019-02-01 N/A 2021-02-01
cabazitaxel 137421 Jevtana Sanofi-aventis Canada Inc. N/A 2011-06-16 2017-06-16 Yes 2019-12-16
canakinumab 131009 Ilaris Novartis Pharmaceuticals Canada Inc. N/A 2010-02-26 2016-02-26 Yes 2018-08-26
catridecacog 152228 Tretten Novo Nordisk Canada Inc. N/A 2012-07-19 2018-07-19 Yes 2021-01-19
catumaxomab 142629 Removab Fresenius Biotech GmbH N/A 2012-05-11 2018-05-11 N/A 2020-05-11
ceftobiprole medocaril 112752 Zeftera Janssen Inc. N/A 2008-06-26 2014-06-26 N/A 2016-06-26
certolizumab pegol 120296 Cimzia UCB Canada Inc. N/A 2009-08-12 2015-08-12 N/A 2017-08-12
ciclesonide 101419 Alvesco Takeda Canada Inc. OmnarisOmnaris HFA
2006-09-11 2012-09-11 Yes 2015-03-11
clevidipine 125287 Cleviprex Chiesi Farmaceutici S.p.A. N/A 2011-04-15 2017-04-15 N/A 2019-04-15
clofarabine 121874 Clolar Sanofi-aventis Canada Inc. N/A 2009-07-16 2015-07-16 Yes 2018-01-16
colesevelam hydrochloride 133463 Lodalis Valeant Canada LP / Valeant Canada S.E.C.
N/A 2011-09-22 2017-09-22 N/A 2019-09-22
collagenase clostridium histolyticum
147788 Xiaflex Endo Ventures Ltd. N/A 2012-07-05 2018-07-05 N/A 2020-07-05
crizotinib 145155 Xalkori Pfizer Canada Inc. N/A 2012-04-25 2018-04-25 Yes 2020-10-25
dabigatran etexilate mesilate 114887 Pradaxa Boehringer Ingelheim (Canada) Ltd. N/A 2008-06-10 2014-06-10 N/A 2016-06-10
daptomycin 102320 Cubicin Cubist Pharmaceuticals, Incorporated N/A 2007-09-24 2013-09-24 Yes 2016-03-24
darunavir ethanolate 103324 Prezista Janssen Inc. N/A 2006-07-28 2012-07-28 Yes 2015-01-28
dasatinib monohydrate 104993 Sprycel Bristol-Myers Squibb Canada N/A 2007-03-26 2013-03-26 N/A 2015-03-26
deferasirox 099621 Exjade Novartis Pharmaceuticals Canada Inc. N/A 2006-10-18 2012-10-18 Yes 2015-04-18
Page 21 of 34 2021-04-29
Products for Human Use - Expired Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
degarelix acetate 120421 Firmagon Ferring Inc. N/A 2009-11-16 2015-11-16 N/A 2017-11-16
denosumab 121139 Prolia Amgen Canada Inc. Xgeva 2010-08-06 2016-08-06 N/A 2018-08-06
desvenlafaxine succinate 115439 Pristiq Pfizer Canada Inc. N/A 2009-02-04 2015-02-04 Yes 2017-08-04
dexmedetomidine hydrochloride
126931 Precedex Pfizer Canada Inc. N/A 2009-12-09 2015-12-09 Yes 2018-06-09
dienogest 132174 Visanne Bayer Inc. Natazia 2011-10-12 2017-10-12 Yes 2020-04-12
doripenem monohydrate 113640 Doribax Janssen Inc. N/A 2009-09-02 2015-09-02 N/A 2017-09-02
dronedarone hydrochloride 121065 Multaq Sanofi-aventis Canada Inc. N/A 2009-08-11 2015-08-11 N/A 2017-08-11
duloxetine hydrochloride 110028 Cymbalta Eli Lilly Canada Inc. N/A 2007-11-01 2013-11-01 Yes 2016-05-01
eculizumab 122467 Soliris Alexion Pharma International Sàrl N/A 2009-01-28 2015-01-28 Yes 2017-07-28
eltrombopag olamine 123984 Revolade Novartis Pharmaceuticals Canada Inc. N/A 2011-01-12 2017-01-12 Yes 2019-07-12
elvitegravir, cobicistat 152198 Stribild Gilead Sciences Canada Inc. TybostVitektaPrezcobixEvotazGenvoyaSymtuza
2012-11-26 2018-11-26 N/A 2020-11-26
eplerenone 120440 Inspra Pfizer Canada Inc. N/A 2009-02-26 2015-02-26 Yes 2017-08-26
eribulin mesylate 141946 Halaven Eisai Limited N/A 2011-12-14 2017-12-14 N/A 2019-12-14
etravirine 113100 Intelence Janssen Inc. N/A 2008-03-27 2014-03-27 Yes 2016-09-27
everolimus 125809 Afinitor Novartis Pharmaceuticals Canada Inc. Certican 2009-12-14 2015-12-14 Yes 2018-06-14
Page 22 of 34 2021-04-29
Products for Human Use - Expired Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
exenatide 128932 Byetta AstraZeneca Canada Inc. Bydureon 2011-01-13 2017-01-13 N/A 2019-01-13
ezogabine 134659 Potiga GlaxoSmithKline Inc. N/A 2012-10-18 2018-10-18 N/A 2020-10-18
fampridine 132859 Fampyra Biogen Idec Canada Inc. N/A 2012-02-10 2018-02-10 N/A 2020-02-10
febuxostat 129969 Uloric Takeda Canada Inc. N/A 2010-09-22 2016-09-22 N/A 2018-09-22
ferumoxytol 133250 Feraheme AMAG Pharmaceuticals Inc. N/A 2011-12-08 2017-12-08 N/A 2019-12-08
fesoterodine fumarate 142326 Toviaz Pfizer Canada Inc. N/A 2012-02-09 2018-02-09 Yes 2020-08-09
fidaxomicin 151086 Dificid Merck Canada Inc. N/A 2012-06-07 2018-06-07 N/A 2020-06-07
fingolimod hydrochloride 137516 Gilenya Novartis Pharmaceuticals Canada Inc. N/A 2011-03-09 2017-03-09 N/A 2019-03-09
fludeoxyglucose 18F 091404 Cantrace Ipet Pharmaceuticals Inc. N/A 2006-07-27 2012-07-27 N/A 2014-07-27
fluticasone furoate 107372 Avamys GlaxoSmithKline Inc. N/A 2007-08-14 2013-08-14 Yes 2016-02-14
gadofosveset trisodium 096420 Vasovist Berlex Canada Inc. N/A 2006-10-31 2012-10-31 N/A 2014-10-31
gadoxetate disodium 127609 Primovist Bayer Inc. N/A 2010-01-14 2016-01-14 N/A 2018-01-14
golimumab 120525 Simponi Janssen Inc. N/A 2009-04-07 2015-04-07 N/A 2017-04-07
human C1 esterase inhibitor 121221 Berinert CSL Behring Canada Inc. Haegarda 2010-05-31 2016-05-31 N/A 2018-05-31
idebenone 117672 Catena Santhera Pharmaceuticals Ltd. N/A 2008-07-23 2014-07-23 Yes 2017-01-23
idursulfase 109857 Elaprase Shire Human Genetic Therapies, Inc. N/A 2007-06-13 2013-06-13 Yes 2015-12-13
indacaterol maleate 143984 Onbrez Breezhaler Novartis Pharmaceuticals Canada Inc. Ultibro Breezhaler 2011-12-06 2017-12-06 N/A 2019-12-06
Page 23 of 34 2021-04-29
Products for Human Use - Expired Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
influenza virus type A (H1N1), influenza virus type A (H3N2), influenza virus type B
129379 FluMist AstraZeneca Canada Incorporated FluMist Quadrivalent 2010-06-22 2016-06-22 Yes 2018-12-22
ingenol mebutate 153285 Picato Leo Pharma Inc. N/A 2013-01-30 2019-01-30 N/A 2021-01-30
ipilimumab 138178 Yervoy Bristol-Myers Squibb Canada N/A 2012-02-01 2018-02-01 Yes 2020-08-01
lacosamide 116632 Vimpat UCB Canada Inc. N/A 2010-09-30 2016-09-30 N/A 2018-09-30
lanreotide 098949 Somatuline Autogel Ipsen Biopharm Limited N/A 2006-07-17 2012-07-17 N/A 2014-07-17
lanthanum carbonate 102240 Fosrenol Shire BioChem Inc. N/A 2006-10-17 2012-10-17 N/A 2014-10-17
lapatinib ditosylate 110294 Tykerb Novartis Pharmaceuticals Canada Inc. N/A 2009-05-15 2015-05-15 N/A 2017-05-15
lenalidomide 111952 Revlimid Celgene N/A 2008-01-17 2014-01-17 N/A 2016-01-17
linagliptin 140881 Trajenta Boehringer Ingelheim (Canada) Ltd. JentaduetoGlyxambi
2011-07-28 2017-07-28 N/A 2019-07-28
liraglutide 119928 Victoza Novo Nordisk Canada Inc. SaxendaXultophy
2010-05-21 2016-05-21 N/A 2018-05-21
lisdexamfetamine dimesylate 120534 Vyvanse Shire Pharma Canada ULC. N/A 2009-02-19 2015-02-19 Yes 2017-08-19
loteprednol etabonate 117199 Alrex Bausch & Lomb Inc. LotemaxLotemax OintmentLotemax Gel
2008-12-23 2014-12-23 N/A 2016-12-23
lumiracoxib 102465 Prexige Novartis Pharmaceuticals Canada Inc. N/A 2006-11-02 2012-11-02 N/A 2014-11-02
lurasidone hydrochloride 145406 Latuda Sunovion Pharmaceuticals Canada Inc. N/A 2012-06-13 2018-06-13 Yes 2020-12-13
maraviroc 112435 Celsentri ViiV Healthcare ULC N/A 2007-09-21 2013-09-21 N/A 2015-09-21
Page 24 of 34 2021-04-29
Products for Human Use - Expired Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
methoxy polyethylene gycol epoetin beta
106461 Mircera Hoffmann-La Roche Ltd. N/A 2008-03-31 2014-03-31 N/A 2016-03-31
methylnaltrexone bromide 114266 Relistor Salix Pharmaceuticals, Inc. N/A 2008-03-28 2014-03-28 N/A 2016-03-28
micafungin sodium 078577 Mycamine Astellas Pharma Canada, Inc. N/A 2007-05-22 2013-05-22 N/A 2015-05-22
mirabegron 153806 Myrbetriq Astellas Pharma Canada Inc. N/A 2013-03-06 2019-03-06 N/A 2021-03-06
natalizumab 093001 Tysabri Biogen Idec Canada Inc. N/A 2006-09-28 2012-09-28 N/A 2014-09-28
nebivolol hydrochloride 152353 Bystolic Allergan Inc. N/A 2012-12-21 2018-12-21 N/A 2020-12-21
nelarabine 099994 Atriance Novartis Pharmaceuticals Canada Inc. N/A 2007-09-22 2013-09-22 Yes 2016-03-22
nepafenac 114004 Nevanac Alcon Canada Inc. Ilevro 2008-04-17 2014-04-17 N/A 2016-04-17
nesiritide 111760 Natrecor Janssen Inc. N/A 2007-11-08 2013-11-08 N/A 2015-11-08
nilotinib hydrochloride monohydrate
110305 Tasigna Novartis Pharmaceuticals Canada Inc. N/A 2008-09-09 2014-09-09 N/A 2016-09-09
ofatumumab 128188 Arzerra Novartis Pharmaceuticals Canada Inc. N/A 2012-03-09 2018-03-09 N/A 2020-03-09
olmesartan medoxomil 115991 Olmetec Merck Canada Inc. Olmetec Plus 2008-10-28 2014-10-28 Yes 2017-04-28
oxaliplatin 109965 Eloxatin Sanofi-aventis Canada Inc. N/A 2007-06-15 2013-06-15 Yes 2015-12-15
paliperidone 108748 Invega Janssen Inc. Invega Sustenna 2007-09-26 2013-09-26 Yes 2016-03-26
palonosetron hydrochloride 145491 Aloxi Purdue Pharma Akynzeo 2012-03-14 2018-03-14 N/A 2020-03-14
panitumumab 105601 Vectibix Amgen Canada Inc. N/A 2008-04-03 2014-04-03 N/A 2016-04-03
pazopanib hydrochloride 128332 Votrient Novartis Pharmaceuticals Canada Inc. N/A 2010-05-27 2016-05-27 N/A 2018-05-27
Page 25 of 34 2021-04-29
Products for Human Use - Expired Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
pertuzumab 158419 Perjeta Hoffmann-La Roche Limited Perjeta-Herceptin Combo PackPhesgo
2013-04-12 2019-04-12 N/A 2021-04-12
pirfenidone 153849 Esbriet Hoffmann-La Roche Limited N/A 2012-10-01 2018-10-01 N/A 2020-10-01
plerixafor 142638 Mozobil Sanofi-aventis Canada Inc. N/A 2011-12-08 2017-12-08 N/A 2019-12-08
pneumococcal polysaccharide serotype 1, 3, 5, 6A, 7F, 19A conjugated to diphtheria CRM197 protein
122881 Prevnar 13 Pfizer Canada Inc. N/A 2009-12-21 2015-12-21 Yes 2018-06-21
pneumococcal polysaccharide serotype 1, 4, 5, 6B, 7F, 9V, 14, 23F conjugated to protein D carrier protein; serotype 18C conjugated to tetanus toxoid carrier protein; serotype 19F conjugated to diphtheria toxoid carrier protein
119056 Synflorix GlaxoSmithKline Inc. N/A 2008-12-11 2014-12-11 Yes 2017-06-11
posaconazole 108193 Posanol Merck Canada Inc. N/A 2007-03-26 2013-03-26 Yes 2015-09-26
prasugrel hydrochloride 121143 Effient Eli Lilly Canada Inc. N/A 2010-04-16 2016-04-16 Yes 2018-10-16
prucalopride succinate 141157 Resotran Janssen Inc. N/A 2011-12-07 2017-12-07 N/A 2019-12-07
raltegravir potassium 113408 Isentress Merck Frosst Canada Inc. N/A 2007-11-27 2013-11-27 Yes 2016-05-27
ranibizumab 110233 Lucentis Novartis Opthalmics, Novartis Pharmaceuticals
N/A 2007-06-26 2013-06-26 N/A 2015-06-26
rasagiline mesylate 101846 Azilect Teva Pharmaceuticals Industries Ltd. N/A 2006-08-17 2012-08-17 N/A 2014-08-17
Page 26 of 34 2021-04-29
Products for Human Use - Expired Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
recombinant human papillomavirus type 11 L1, type 16 L1, type 18 L1, type 6 L1 protein
102682 Gardasil Merck Frosst Canada Ltd. N/A 2006-07-10 2012-07-10 Yes 2015-01-10
remestemcel-L 150026 Prochymal Osiris Therapeutics Inc. N/A 2012-05-17 2018-05-17 Yes 2020-11-17
retapamulin 109037 Altargo GlaxoSmithKline Inc. N/A 2008-03-19 2014-03-19 Yes 2016-09-19
rilpivirine hydrochloride 137484 Edurant Janssen Inc. CompleraOdefseyJuluca
2011-07-21 2017-07-21 Yes 2020-01-21
rivaroxaban 119111 Xarelto Bayer Healthcare N/A 2008-09-15 2014-09-15 N/A 2016-09-15
roflumilast 127683 Daxas Takeda Canada Inc. N/A 2010-11-23 2016-11-23 N/A 2018-11-23
romiplostim 117327 Nplate Amgen Canada Inc. N/A 2009-02-19 2015-02-19 Yes 2017-08-19
rotavirus RIX4414 strain, live, attenuated (human)
109624 Rotarix GlaxoSmithKline Inc. N/A 2007-10-09 2013-10-09 Yes 2016-04-09
rotavirus vaccine, live, oral type G1, type G2, type G3, type G4, type P1(8) (human)
100399 Rotateq Merck Frosst Canada Ltd. N/A 2006-08-01 2012-08-01 Yes 2015-02-01
rotigotine 145523 Neupro UCB Canada Inc. N/A 2013-03-21 2019-03-21 N/A 2021-03-21
rubidium 82 chloride 138823 Ruby-Fill Jubilant Draximage Inc. N/A 2011-09-20 2017-09-20 N/A 2019-09-20
rufinamide 139913 Banzel Eisai Limited N/A 2011-06-22 2017-06-22 Yes 2019-12-22
ruxolitinib phosphate 151723 Jakavi Novartis Pharmaceuticals Canada Inc. N/A 2012-06-19 2018-06-19 N/A 2020-06-19
sapropterin dihydrochloride 128151 Kuvan BioMarin Pharmaceutical Inc. N/A 2010-04-30 2016-04-30 Yes 2018-10-30
Page 27 of 34 2021-04-29
Products for Human Use - Expired Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
saxagliptin hydrochloride 123854 Onglyza AstraZeneca Canada Inc. KomboglyzeQtern
2009-09-14 2015-09-14 N/A 2017-09-14
silodosin 121740 Rapaflo Purdue Pharma N/A 2011-01-11 2017-01-11 N/A 2019-01-11
sitagliptin phosphate 103039 Januvia Merck Frosst Canada Ltd. JanumetJanumet XR
2007-12-14 2013-12-14 N/A 2015-12-14
sitaxsentan sodium 101934 Thelin Pfizer Canada Inc. N/A 2007-05-30 2013-05-30 N/A 2015-05-30
sodium fluoride 18F 145561 NaF Plus Isologic Innovative Radiopharmaceuticals Ltd.
N/A 2013-02-11 2019-02-11 N/A 2021-02-11
sorafenib 102070 Nexavar Bayer Inc. N/A 2006-07-28 2012-07-28 N/A 2014-07-28
tapentadol hydrochloride 133167 Nucynta CR Janssen Inc. Nucynta IRNucynta Extended Release
2010-12-02 2016-12-02 N/A 2018-12-02
telaprevir 142482 Incivek Vertex Pharmaceuticals (Canada) Inc. N/A 2011-08-16 2017-08-16 N/A 2019-08-10
telavancin hydrochloride 107792 Vibativ Pendopharm Division of de Pharmascience Inc.
N/A 2009-09-29 2015-09-29 N/A 2017-09-29
telbivudine 104469 Sebivo Novartis Pharmaceuticals Canada Inc. N/A 2006-11-28 2012-11-28 N/A 2014-11-28
temsirolimus 109201 Torisel Pfizer Canada Inc. N/A 2007-12-21 2013-12-21 Yes 2016-06-21
ticagrelor 132218 Brilinta AstraZeneca Canada Incorporated N/A 2011-05-30 2017-05-30 N/A 2019-05-30
tigecycline 094870 Tygacil Pfizer Canada Inc. N/A 2006-09-14 2012-09-14 N/A 2014-09-14
tocilizumab 121089 Actemra Hoffmann-La Roche Ltd. N/A 2010-04-30 2016-04-30 Yes 2018-10-30
tolvaptan 139413 Samsca Otsuka Pharmaceutical Co. Ltd. Jinarc 2011-07-25 2017-07-25 N/A 2019-07-25
trabectedin 124729 Yondelis Janssen Inc. N/A 2010-05-13 2016-05-13 N/A 2018-05-13
ustekinumab 114272 Stelara Janssen Inc. N/A 2008-12-12 2014-12-12 N/A 2016-12-12
Page 28 of 34 2021-04-29
Products for Human Use - Expired Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Pediatric Extension Yes / No
Data Protection Ends
Register Of Innovative Drugs
vandetanib 126822 Caprelsa Genzyme Canada, a division of Sanofi-aventis Canada Inc.
N/A 2012-01-12 2018-01-12 N/A 2020-01-12
varenicline tartrate 104007 Champix Pfizer Canada Inc. N/A 2007-01-24 2013-01-24 Yes 2015-07-24
velaglucerase alfa 132604 Vpriv Shire Human Genetic Therapies, Inc. N/A 2010-10-01 2016-10-01 Yes 2019-04-01
vemurafenib 148693 Zelboraf Hoffmann-La Roche Ltd. N/A 2012-02-15 2018-02-15 N/A 2020-02-15
vorinostat 104562 Zolinza Merck Frosst Canada Ltd. N/A 2009-06-11 2015-06-11 N/A 2017-06-11
ziprasidone hydrochloride monohydrate
078188 Zeldox Pfizer Canada Inc. N/A 2007-08-27 2013-08-27 Yes 2016-02-27
zucapsaicin 121952 Zuacta Sanofi-aventis Canada Inc. N/A 2010-07-15 2016-07-15 N/A 2018-07-15
*The medicinal ingredient not previously approved in a drug by the Minister and that is not a variation of a previously approved medicinal ingredient (subsection C.08.004.1(1) of the Food and Drug Regulations ).
Page 29 of 34 2021-04-29
Products for Veterinary Use - Active Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal
Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Data Protection Ends
afoxolaner 163768 Nexgard Boehringer Ingelheim Animal Health Canada Inc.
Nexgard SpectraNexgard Combo
2014-07-08 2020-07-08 2022-07-08
amlodipine besilate 218786 Amodip Flavoured Tablets Ceva Animal Health Inc. N/A 2020-03-25 2026-03-25 2028-03-25
avilamycin 156949 Surmax 100 Premix Elanco Canada Limited Surmax 200 Premix 2014-02-18 2020-02-18 2022-02-18
bedinvetmab 237723 Librela Zoetis Canada Inc. N/A 2021-02-01 2027-02-01 2029-02-01
ciclesonide 200882 Aservo Equihaler Boehringer Ingelheim Animal Health Canada Inc.
N/A 2020-04-30 2026-04-30 2028-04-30
clodronate disodium tetrahydrate
172789 Osphos Injection Dechra Ltd. N/A 2015-05-06 2021-05-06 2023-05-06
closantel sodium 180678 Flukiver Elanco Division Eli Lilly Canada Inc N/A 2015-11-24 2021-11-24 2023-11-24
derquantel 184844 Startect Zoetis Canada Inc. N/A 2016-04-27 2022-04-27 2024-04-27
fluralaner 166320 Bravecto Intervet Canada Corp. VitrectoBravecto One
2014-05-23 2020-05-23 2022-05-23
grapiprant 211760 Galliprant Elanco Canada Limited N/A 2019-01-08 2025-01-08 2027-01-08
insulin human (recombinant) 150211 Prozinc Boehringer Ingelheim Animal Health Canada
N/A 2013-04-24 2019-04-24 2021-04-24
lotilaner 193712 Credelio Elanco Canada Limited N/A 2017-12-29 2023-12-29 2025-12-29
lubabegron 166199 Experior 10 Elanco Canada Limited Experior 50 2018-11-07 2024-11-07 2026-11-07
methadone hydrochloride 226217 Comfortan Eurovet Animal Health B.V. N/A 2020-02-25 2026-02-25 2028-02-25
mirtazapine 232197 Mirataz Dechra Ltd. N/A 2020-09-08 2026-09-08 2028-09-08
Register Of Innovative Drugs
Page 30 of 34 2021-04-29
Products for Veterinary Use - Active Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal
Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Data Protection Ends
Register Of Innovative Drugs
oclacitinib maleate 159090 Apoquel Zoetis Canada Inc. N/A 2014-07-15 2020-07-15 2022-07-15
peforelin 190986 Maprelin XP-10 Modern Veterinary Therapeutics LLC N/A 2017-06-19 2023-06-19 2025-06-19
pegbovigrastim 148171 Imrestor Elanco Division Eli Lilly Canada Inc. N/A 2016-03-09 2022-03-09 2024-03-09
pergolide mesylate 158770 Prascend Boehringer Ingelheim Canada Ltd. N/A 2013-09-05 2019-09-05 2021-09-05
pradofloxacin 161227 Veraflox Elanco Canada Limited N/A 2015-01-29 2021-01-29 2023-01-29
sarolaner 177679 Simparica Zoetis Canada Inc. Revolution PlusSimparica Trio
2016-02-11 2022-02-11 2024-02-11
telmisartan 158760 Semintra Boehringer Ingelheim Animal Health Canada Inc.
N/A 2013-12-12 2019-12-12 2021-12-12
terbinafine 170344 Osurnia Dechra Ltd. N/A 2015-03-26 2021-03-26 2023-03-26
tetracosactide 228462 Cosacthen Dechra Ltd. N/A 2020-04-27 2026-04-27 2028-04-27
tiludronic acid (as tiludronate disodium)
171467 Tildren CEVA Animal Health N/A 2014-12-22 2020-12-22 2022-12-22
triptorelin (as triptorelin acetate)
161303 Ovugel United-AH II, LLC N/A 2014-04-25 2020-04-25 2022-04-25
*The medicinal ingredient not previously approved in a drug by the Minister and that is not a variation of a previously approved medicinal ingredient (subsection C.08.004.1(1) of the Food and Drug Regulations ).
Page 31 of 34 2021-04-29
Products for Veterinary Use - Expired Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal
Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Data Protection Ends
acetaminophen 110139 Pracetam 20% O.S. Ceva Animal Health Inc. N/A 2009-03-05 2015-03-05 2017-03-05
buprenorphine hydrochloride 126077 Vetergesic Multidose Sogeval UK Limited N/A 2010-02-03 2016-02-03 2018-02-03
cefovecin sodium 110061 Convenia Zoetis Canada Inc. N/A 2007-05-30 2013-05-30 2015-05-30
cefpodoxime proxetil 149164 Simplicef Zoetis Canada Inc. N/A 2012-12-06 2018-12-06 2020-12-06
cephalexin monohydrate 126970 Vetolexin Vétoquinol N.-A Inc. Cefaseptin 2010-06-24 2016-06-24 2018-06-24
dibotermin alfa (rhBMP-2) 148153 Truscient Zoetis Canada Inc. N/A 2012-11-20 2018-11-20 2020-11-20
dirlotapide 110110 Slentrol Zoetis Canada Inc. N/A 2008-08-14 2014-08-14 2016-08-14
emamectin benzoate 109976 Slice Intervet Canada Ltd. N/A 2009-06-29 2015-06-29 2017-06-29
emodepside 112103 / 112106 / 112107
Profender Bayer Healthcare, Animal Health Division N/A 2008-08-28 2014-08-28 2016-08-28
firocoxib 110661 / 110379
Previcox Merial Canada Inc. N/A 2007-09-28 2013-09-28 2015-09-28
fluoxetine hydrochloride 109825 / 109826 / 110429
Reconcile Elanco, Division Eli Lilly Canada Inc. N/A 2008-03-28 2014-03-28 2016-03-28
gamithromycin 125823 Zactran Merial Canada Inc. N/A 2010-03-29 2016-03-29 2018-03-29
Register Of Innovative Drugs
Page 32 of 34 2021-04-29
Products for Veterinary Use - Expired Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal
Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Data Protection Ends
Register Of Innovative Drugs
gonadotropin releasing factor analogue - protein conjugate
140525 Improvest Zoetis Canada Inc. N/A 2011-06-22 2017-06-22 2019-06-22
ibafloxacin 110655 / 110657
Ibaflin gel Intervet Canada Ltd. N/A 2008-01-15 2014-01-15 2016-01-15
imidapril hydrochloride 110445 / 110450 / 110476
Prilium Vétoquinol N.-A Inc. N/A 2007-07-12 2013-07-12 2015-07-12
itraconazole 109769 Itrafungol Elanco, Division Eli Lilly Canada Inc. N/A 2008-09-23 2014-09-23 2016-09-23
maropitant 110342 / 110344 / 110347 / 110348
Cerenia Zoetis Canada Inc. N/A 2007-09-20 2013-09-20 2015-09-20
mitratapide 111600 Yarvitan Janssen Pharmaceutica N.V. N/A 2009-02-20 2015-02-20 2017-02-20
mometasone furoate monohydrate
110289 Mometamax Intervet Canada Corp. N/A 2010-02-22 2016-02-22 2018-02-22
permethrin 133818 Oridermyl Vétoquinol N.- A Inc. N/A 2011-02-18 2017-02-18 2019-02-18
phenobarbital 142445 Epiphen Vétoquinol N.- A Inc. N/A 2012-04-04 2018-04-04 2020-04-04
ramipril 110296 / 110297 / 110298
Vasotop Intervet Canada Ltd. N/A 2008-09-05 2014-09-05 2016-09-05
robenacoxib 128703 Onsior Elanco Canada Limited N/A 2011-10-03 2017-10-03 2019-10-03
sevoflurane 110109 Sevoflo Zoetis Canada Inc. N/A 2008-03-28 2014-03-28 2016-03-28
Page 33 of 34 2021-04-29
Products for Veterinary Use - Expired Data Protection Period
Medicinal Ingredient(s)* Submission Number Innovative Drug Manufacturer
Drug(s) Containing the Medicinal
Ingredient / Variations
Notice of Compliance
Date yyyy-mm-dd
6 Year "No File" Date
Data Protection Ends
Register Of Innovative Drugs
spinosad 112198 / 112199 / 112202 / 112203 / 112204
Comfortis Elanco, Division Eli Lilly Canada Inc. Trifexis 2009-08-24 2015-08-24 2017-08-24
tepoxalin 109950 / 109956 / 109963
Zubrin Schering Plough Canada Inc. N/A 2007-10-01 2013-10-01 2015-10-01
thiamazole 125706 Felimazole Dechra Ltd. N/A 2009-08-25 2015-08-25 2017-08-25
tildipirosin 148052 Zuprevo Intervet Canada Corp. N/A 2012-06-13 2018-06-13 2020-06-13
toceranib phosphate 123643 Palladia Zoetis Canada Inc. N/A 2009-12-01 2015-12-01 2017-12-01
toltrazuril 122525 Baycox Bayer Inc., Bayer Healthcare Animal Health Division
N/A 2010-08-20 2016-08-20 2018-08-20
trilostane 110023 / 110025 / 110221 / 113566
Vetoryl Dechra Ltd. N/A 2009-01-30 2015-01-30 2017-01-30
tulathromycin 112161 Draxxin Pfizer Canada Inc., Animal Health Group N/A 2006-08-31 2012-08-31 2014-08-31
zilpaterol hydrochloride 110019 Zilmax Intervet Canada Ltd. N/A 2009-03-18 2015-03-18 2017-03-18
*The medicinal ingredient not previously approved in a drug by the Minister and that is not a variation of a previously approved medicinal ingredient (subsection C.08.004.1(1) of the Food and Drug Regulations ).
The Minister of Health maintains a register of innovative drugs pursuant to sub-section C.08.004.1(9) of the Food and Drug Regulations .
Page 34 of 34 2021-04-29